Barry R, Thompson E Outcomes after rib fractures in geriatric blunt trauma patients. Am J Surg. 2018 Jun;215(6):1020-1023. doi: 10.1016/j.amjsurg.2018.03.011. Epub 2018 Mar 9.
Chan YH, Zeng YZ, Wu HC, Wu MC, Sun HM Effective Pneumothorax Detection for Chest X-Ray Images Using Local Binary Pattern and Support Vector Machine. J Healthc Eng. 2018 Apr 3;2018:2908517. doi: 10.1155/2018/2908517. eCollection 2018.
Ding W, Shen Y, Yang J, He X, Zhang M Diagnosis of pneumothorax by radiography and ultrasonography: a meta-analysis. Chest. 2011 Oct;140(4):859-866. doi: 10.1378/chest.10-2946. Epub 2011 May 5. Review.
Misthos P, Kakaris S, Sepsas E, Athanassiadi K, Skottis I A prospective analysis of occult pneumothorax, delayed pneumothorax and delayed hemothorax after minor blunt thoracic trauma. Eur J Cardiothorac Surg. 2004 May;25(5):859-64.
Patel BH, Lew CO, Dall T, Anderson CL, Rodriguez R, Langdorf MI Chest tube output, duration, and length of stay are similar for pneumothorax and hemothorax seen only on computed tomography vs. chest radiograph. Eur J Trauma Emerg Surg. 2019 Aug 5. doi: 1
Tam MM Occult pneumothorax in trauma patients: should this be sought in the focused assessment with sonography for trauma examination? Emerg Med Australas. 2005 Oct-Dec;17(5-6):488-93.
Wilson H, Ellsmere J, Tallon J, Kirkpatrick A Occult pneumothorax in the blunt trauma patient: tube thoracostomy or observation? Injury. 2009 Sep;40(9):928-31. doi: 10.1016/j.injury.2009.04.005. Epub 2009 Jun 17.
Yang S, Netterwald J, Wang W, Zhu H Characterization of the elements and proteins responsible for interferon-stimulated gene induction by human cytomegalovirus. J Virol. 2005 Apr;79(8):5027-34.
Occult Pneumothorax in Patients With Blunt or Penetrating Trauma: A Descriptive, Cross-sectional Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
